Sectoral Asset Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $372K | Buy |
|
|||||
|
2025
Q1 | $321K | Sell |
|
|||||
|
2024
Q4 | $1.61M | Sell |
|
|||||
|
2024
Q3 | $1.44M | Buy |
|
|||||
|
2024
Q2 | $542K | Sell |
|
|||||
|
2024
Q1 | $579K | Sell |
|
|||||
|
2023
Q4 | $586K | Buy |
|
|||||
|
2023
Q3 | $454K | Buy |
|
|||||
|
2023
Q2 | $326K | Buy |
|
|||||
|
2023
Q1 | $283K | Hold |
|
|||||
|
2022
Q4 | $334K | Sell |
|
|||||
|
2022
Q3 | $324K | Hold |
|
|||||
|
2022
Q2 | $297K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $1.72M | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $836K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $9.24M | Sell |
|
|||||
|
2017
Q4 | $11M | Sell |
|
|||||
|
2017
Q3 | $14.3M | Sell |
|
|||||
|
2017
Q2 | $11M | Sell |
|
|||||
|
2017
Q1 | $36.8M | Buy |
|
|||||
|
2016
Q4 | $29M | Sell |
|
|||||
|
2016
Q3 | $40.7M | Sell |
|
|||||
|
2016
Q2 | $46M | Sell |
|
|||||
|
2016
Q1 | $65.3M | Buy |
|
|||||
|
2015
Q4 | $23.6M | Buy |
|